Title:
PYRIMIDOPYRROLE COMPOUND
Document Type and Number:
WIPO Patent Application WO/2022/062601
Kind Code:
A1
Abstract:
Provided are a pyrimidopyrrole compound as represented by formula (Ia) or a pharmaceutically acceptable salt thereof, a pharmaceutical composition and a preparation method therefor, and use thereof as a JAK3 and/or BTK inhibitor.
Inventors:
TANG FENG (CN)
LIU LIFENG (CN)
JIANG LEI (CN)
YAN YUXI (CN)
ZHANG GUOBAO (CN)
CHEN CHIA-CHUN (CN)
ZHOU FENG (CN)
TANG RENHONG (CN)
REN JINSHENG (CN)
LIU LIFENG (CN)
JIANG LEI (CN)
YAN YUXI (CN)
ZHANG GUOBAO (CN)
CHEN CHIA-CHUN (CN)
ZHOU FENG (CN)
TANG RENHONG (CN)
REN JINSHENG (CN)
Application Number:
PCT/CN2021/106877
Publication Date:
March 31, 2022
Filing Date:
July 16, 2021
Export Citation:
Assignee:
JIANGSU SIMCERE PHARM CO LTD (CN)
International Classes:
A61K31/519; C07D487/04; A61P35/00; A61P37/00
Domestic Patent References:
| WO2019132560A1 | 2019-07-04 | |||
| WO2019132562A1 | 2019-07-04 | |||
| WO2021147952A1 | 2021-07-29 |
Foreign References:
| CN111527088A | 2020-08-11 | |||
| CN109311896A | 2019-02-05 | |||
| CN103814030A | 2014-05-21 |
Attorney, Agent or Firm:
LINDA LIU & PARTNERS (CN)
Download PDF: